Updated 12 Oct 2026 · BfArM PharmNet.Bund register
Germany Medicine Shortages Tracker
Every medicine supply shortage reported to Germany's Federal Institute for Drugs and Medical Devices (BfArM) - the affected medicine, active substance, manufacturer, dosage form and BfArM's own severity classification (versorgungskritisch / versorgungsrelevant). Searchable, refreshed twice daily.
937
Shortages tracked
196
Supply-critical
252
Hospital-relevant
Showing 937 shortages
Reported
Hospital-relevant Reported 12.10.2026
Amitriptylin Micro Labs 22,1 mg Filmtabletten
Amitriptylinhydrochlorid
2 clinical trials →
Reported
Hospital-relevant Reported 12.10.2026
Amitriptylin Micro Labs 22,1 mg Filmtabletten
Amitriptylinhydrochlorid
2 clinical trials →
Reported
Reported 12.10.2026
Cephalex-CT 1000mg Filmtabletten
Cefalexin-Monohydrat
Reported
Reported 12.10.2026
Cephalex-CT 1000mg Filmtabletten
Cefalexin-Monohydrat
Reported
Reported 12.10.2026
Clomifen-ratiopharm 50mg Tabletten
Clomifencitrat
Reported
Reported 12.10.2026
Galantamin-ratiopharm 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 12.10.2026
Galantamin-ratiopharm 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 12.10.2026
Galantamin-ratiopharm 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 12.10.2026
Galantamin-ratiopharm 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Hospital-relevant Reported 12.10.2026
Risperidon-ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
Risperidon
8 clinical trials →
Reported
Hospital-relevant Reported 12.10.2026
Risperidon-ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
Risperidon
8 clinical trials →
Reported
Hospital-relevant Reported 12.10.2026
Risperidon-ratiopharm 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
Risperidon
8 clinical trials →
Reported
Hospital-relevant Reported 12.10.2026
Risperidon-ratiopharm 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
Risperidon
8 clinical trials →
Reported
Hospital-relevant Reported 12.10.2026
Risperidon-ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
Risperidon
8 clinical trials →
Reported
Hospital-relevant Reported 12.10.2026
Risperidon-ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
Risperidon
8 clinical trials →
Reported
Reported 12.10.2026
Ribavirin-ratiopharm 200 mg Filmtabletten
Ribavirin
Reported
Reported 12.10.2026
Ribavirin-ratiopharm 200 mg Filmtabletten
Ribavirin
Reported
Reported 12.10.2026
Ribavirin-ratiopharm 200 mg Filmtabletten
Ribavirin
Reported
Reported 12.10.2026
Ribavirin-ratiopharm 400 mg Filmtabletten
Ribavirin
Reported
Reported 12.10.2026
Aciclovir-ratiopharm 50 mg/g Creme
Aciclovir
Reported
Reported 12.10.2026
Aciclovir-ratiopharm 50 mg/g Creme
Aciclovir
Supply-relevant
Hospital-relevant Reported 09.10.2026
Moxifloxacin Micro Labs 5 mg/ml Augentropfen, Lösung
Moxifloxacinhydrochlorid (Ph.Eur.) ((mit Angaben zum Wasser-Gehalt (1:x)))
Supply-relevant
Hospital-relevant Reported 09.10.2026
Escitalopram-Micro Labs 20 mg Filmtabletten
Escitalopramoxalat
Supply-relevant
Hospital-relevant Reported 09.10.2026
Amitriptylin Micro Labs 44,19 mg Filmtabletten
Amitriptylinhydrochlorid
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 09.10.2026
Amitriptylin Micro Labs 88,38 mg Filmtabletten
Amitriptylinhydrochlorid
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 09.10.2026
Amitriptylin Micro Labs 88,38 mg Filmtabletten
Amitriptylinhydrochlorid
2 clinical trials →
Reported
Reported 09.10.2026
Visipaque 270
Iodixanol
Supply-critical
Reported 09.10.2026
Semglee 100 Einheiten/ml Injektionslösung in Fertigpen - OP(5x3ml)
Insulin glargin
4 clinical trials →
Supply-critical
Reported 09.10.2026
Semglee 100 Einheiten/ml Injektionslösung in Fertigpen - OP(5x3ml)
Insulin glargin
4 clinical trials →
Supply-relevant
Reported 09.10.2026
PANTOPRAZOL BASICS 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 09.10.2026
PANTOPRAZOL BASICS 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 09.10.2026
PANTOPRAZOL BASICS 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 09.10.2026
PANTOPRAZOL BASICS 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-critical
Reported 09.10.2026
Nevirapin Mylan 400 mg Retardtabletten
Nevirapin
Supply-critical
Reported 09.10.2026
Nevirapin Mylan 400 mg Retardtabletten
Nevirapin
Reported
Hospital-relevant Reported 09.10.2026
Ropivacainhydrochlorid Kabi 2 mg/ml Infusionslösung
Ropivacainhydrochlorid
36 clinical trials →
Reported
Hospital-relevant Reported 09.10.2026
Ropivacainhydrochlorid Kabi 7,5 mg/ml Injektionslösung
Ropivacainhydrochlorid
36 clinical trials →
Supply-critical
Hospital-relevant Reported 08.10.2026
Cotrim-ratiopharm 400 mg/5 ml + 80 mg/5 ml Konzentrat zur Herstellung einer Infusionslösung
Sulfamethoxazol; Trimethoprim
Reported
Hospital-relevant Reported 08.10.2026
NexoBrid
Konzentrat proteolytischer Enzyme angereichert aus Bromelain
Supply-critical
Reported 08.10.2026
Hydromorphon HEXAL 10 mg/ml Injektions-/Infusionslösung
Hydromorphonhydrochlorid
2 clinical trials →
Supply-critical
Reported 08.10.2026
Hydromorphon HEXAL 10 mg/ml Injektions-/Infusionslösung
Hydromorphonhydrochlorid
2 clinical trials →
Supply-relevant
Reported 08.10.2026
Pramipexol - 1 A Pharma 0,26 mg Retardtabletten
Pramipexoldihydrochlorid-Monohydrat
Supply-relevant
Reported 08.10.2026
Triamhexal 10
Triamcinolonacetonid
Supply-relevant
Reported 08.10.2026
Triamhexal 10
Triamcinolonacetonid
Supply-relevant
Reported 08.10.2026
Triamhexal 10
Triamcinolonacetonid
Supply-relevant
Reported 08.10.2026
Triamhexal 10
Triamcinolonacetonid
Supply-relevant
Reported 08.10.2026
Triamhexal 40
Triamcinolonacetonid
Supply-relevant
Reported 08.10.2026
Triamhexal 40
Triamcinolonacetonid
Supply-relevant
Reported 08.10.2026
Rizatriptan Glenmark 5 mg Schmelztabletten
Rizatriptanbenzoat
Supply-relevant
Hospital-relevant Reported 08.10.2026
Retacrit 2 000 I.E./0,6 ml Injektionslösung in Fertigspritze
Epoetin zeta
Reported
Hospital-relevant Reported 08.10.2026
Zoloft 20 mg/ml Konzentrat zur Herstellung einer Lösung zum Einnehmen
Sertralinhydrochlorid
12 clinical trials →
Reported
Reported 08.10.2026
Luxerm 160 mg/g Creme
Methyl(5-amino-4-oxopentanoat)-hydrochlorid
Reported
Reported 08.10.2026
Olanzapin Glenmark 20 mg Tabletten - OP70
Olanzapin
20 clinical trials →
Reported
Reported 08.10.2026
Olanzapin Glenmark 2,5 mg Tabletten - OP56
Olanzapin
20 clinical trials →
Reported
Reported 08.10.2026
Olanzapin Glenmark 2,5 mg Tabletten - OP70
Olanzapin
20 clinical trials →
Supply-critical
Hospital-relevant Reported 08.10.2026
Dacarbazin Lipomed 1000 mg Pulver zur Herstellung einer Infusionslösung
Dacarbazincitrat
24 clinical trials →
Supply-relevant
Hospital-relevant Reported 08.10.2026
Rizatriptan PUREN 10 mg Tabletten
Rizatriptanbenzoat
Supply-relevant
Hospital-relevant Reported 08.10.2026
Fingolimod PUREN 0,5 mg Hartkapseln
Fingolimodhydrochlorid
8 clinical trials →
Reported
Reported 08.10.2026
ISMN STADA 50 mg Hartkapseln, retardiert
Isosorbidmononitrat
Reported
Reported 08.10.2026
ISMN STADA 20 mg Tabletten
Isosorbidmononitrat
Reported
Reported 08.10.2026
ISMN STADA 20 mg Tabletten
Isosorbidmononitrat
Supply-relevant
Reported 08.10.2026
Bortezomib STADA 2,5 mg/ml Injektionslösung
Bortezomibmannitol
Supply-relevant
Reported 08.10.2026
Aprepitant STADA 125 mg Hartkapseln
Aprepitant
5 clinical trials →
Supply-relevant
Reported 08.10.2026
Aprepitant STADA 125 mg und 80 mg Hartkapseln
Aprepitant
5 clinical trials →
Supply-critical
Hospital-relevant Reported 07.10.2026
L-Thyroxin Henning 75
Levothyroxin-Natrium
7 clinical trials →
Supply-critical
Hospital-relevant Reported 07.10.2026
Sedaconda 100 % V/V Flüssigkeit zur Herstellung eines Dampfs zur Inhalation
Isofluran
5 clinical trials →
Supply-relevant
Hospital-relevant Reported 07.10.2026
Erythromycin Inresa i.v. 1g
Erythromycinlactobionat
Supply-relevant
Hospital-relevant Reported 06.10.2026
Aknenormin 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Hospital-relevant Reported 06.10.2026
Aknenormin 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Hospital-relevant Reported 06.10.2026
Aknenormin 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Hospital-relevant Reported 06.10.2026
Aknenormin 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-critical
Hospital-relevant Reported 06.10.2026
Minprostin E2 Vaginaltabletten
Dinoproston
Supply-relevant
Hospital-relevant Reported 06.10.2026
Volon A 40
Triamcinolonacetonid
Supply-relevant
Hospital-relevant Reported 06.10.2026
Volon A 40
Triamcinolonacetonid
Supply-relevant
Hospital-relevant Reported 06.10.2026
Volon A 40
Triamcinolonacetonid
Reported
Hospital-relevant Reported 06.10.2026
Fixaprost 50 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis
Latanoprost; Timololmaleat
Reported
Hospital-relevant Reported 06.10.2026
Fixaprost 50 Mikrogramm/ml + 5 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis
Latanoprost; Timololmaleat
Reported
Reported 05.10.2026
Eletriptan Bluefish 40 mg Filmtabletten
Eletriptanhydrobromid
Reported
Hospital-relevant Reported 05.10.2026
Dimaval (DMPS) 100 mg Hartkapseln
(RS)-2,3-Bis(sulfanyl)propan-1-sulfonsäure-Natriumsalz-Monohydrat
Supply-critical
Reported 05.10.2026
innohep 4.500 Anti-Xa I.E. Injektionslösung
Tinzaparin-Natrium
7 clinical trials →
Reported
Reported 05.10.2026
Quetiapin beta 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 05.10.2026
Quetiapin beta 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 05.10.2026
Quetiapin beta 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 05.10.2026
Quetiapin beta 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 05.10.2026
Quetiapin beta 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 05.10.2026
Quetiapin beta 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 05.10.2026
Atomoxetin beta 18 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 05.10.2026
Atomoxetin beta 18 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 05.10.2026
Atomoxetin beta 100 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Hospital-relevant Reported 05.10.2026
Dimaval
(RS)-2,3-Bis(sulfanyl)propan-1-sulfonsäure-Natriumsalz-Monohydrat
Reported
Hospital-relevant Reported 05.10.2026
Dimaval
(RS)-2,3-Bis(sulfanyl)propan-1-sulfonsäure-Natriumsalz-Monohydrat
Supply-critical
Reported 05.10.2026
PAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Dinatriumpamidronat
Supply-critical
Reported 05.10.2026
PAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Dinatriumpamidronat
Supply-critical
Reported 05.10.2026
PAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Dinatriumpamidronat
Supply-critical
Reported 05.10.2026
PAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Dinatriumpamidronat
Supply-critical
Reported 05.10.2026
PAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Dinatriumpamidronat
Supply-critical
Reported 05.10.2026
PAMIDRO-cell 3 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Dinatriumpamidronat
Reported
Hospital-relevant Reported 02.10.2026
Nephrotect
Acetylcystein; Alanin; Arginin; Glycin; Histidin; Isoleucin; Leucin; Lysinacetat; Methionin; N-Glycyl-L-tyrosin-Dihydrat; Phenylalanin; Prolin; Serin; Threonin; Tryptophan; Tyrosin; Valin
2 clinical trials →
Reported
Hospital-relevant Reported 02.10.2026
Nephrotect
Acetylcystein; Alanin; Arginin; Glycin; Histidin; Isoleucin; Leucin; Lysinacetat; Methionin; N-Glycyl-L-tyrosin-Dihydrat; Phenylalanin; Prolin; Serin; Threonin; Tryptophan; Tyrosin; Valin
2 clinical trials →
Supply-relevant
Reported 02.10.2026
Mydriaticum Stulln UD
Tropicamid
Supply-relevant
Reported 02.10.2026
Mydriaticum Stulln UD
Tropicamid
Supply-relevant
Reported 02.10.2026
Mydriaticum Stulln UD
Tropicamid
Supply-relevant
Reported 01.10.2026
LEVETIRACETAM BASICS 500 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 01.10.2026
LEVETIRACETAM BASICS 500 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Hospital-relevant Reported 01.10.2026
Urapidil PUREN 30 mg Retardkapseln
Urapidil
Reported
Hospital-relevant Reported 01.10.2026
Clarithromycin Eberth 500 mg Pulver zur Herstellung einer Infusionslösung
Clarithromycinlactobionat
Reported
Reported 01.10.2026
INVEGA 9 mg Retardtabletten - OP28(Blister)
Paliperidon
Reported
Reported 01.10.2026
Quetiapin Accord 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 01.10.2026
Quetiapin Accord 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Supply-critical
Reported 01.10.2026
Pen 0,4 Mega TS - 1 A Pharma
Phenoxymethylpenicillin-Kalium
2 clinical trials →
Supply-critical
Hospital-relevant Reported 01.10.2026
Minprostin E2 Vaginalgel 2mg
Dinoproston
Supply-critical
Reported 01.10.2026
Cefaclor 125 TS - 1 A Pharma
Cefaclor-Monohydrat
2 clinical trials →
Supply-critical
Reported 01.10.2026
Cefaclor 250 TS - 1 A Pharma
Cefaclor-Monohydrat
2 clinical trials →
Supply-critical
Reported 01.10.2026
Pazopanib Viatris 200 mg Filmtabletten
Pazopanibhydrochlorid
10 clinical trials →
Supply-critical
Reported 01.10.2026
Pazopanib Viatris 200 mg Filmtabletten
Pazopanibhydrochlorid
10 clinical trials →
Supply-critical
Reported 01.10.2026
Nilotinib Viatris 50 mg Hartkapseln
Nilotinibhydrochlorid-Dihydrat
12 clinical trials →
Supply-critical
Hospital-relevant Reported 01.10.2026
Arixtra 5 mg/0,4 ml Injektionslösung, Fertigspritze - OP7
Fondaparinux-Natrium
Supply-relevant
Reported 30.09.2026
Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen
Rivaroxaban
51 clinical trials →
Supply-relevant
Hospital-relevant Reported 30.09.2026
Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen
Rivaroxaban
51 clinical trials →
Supply-relevant
Reported 30.09.2026
Prednifluid 10 mg/ml Augentropfensuspension
Prednisolonacetat
77 clinical trials →
Reported
Reported 30.09.2026
metodura ZNT 50 mg Retardtabletten
Metoprololtartrat (Ph.Eur.)
Reported
Reported 30.09.2026
Oxazepam AL 10
Oxazepam
Reported
Reported 30.09.2026
Oxazepam AL 10
Oxazepam
Supply-relevant
Reported 30.09.2026
Aprepitant AL 125 mg und 80 mg Hartkapseln
Aprepitant
5 clinical trials →
Reported
Reported 30.09.2026
Visipaque 320
Iodixanol
Reported
Reported 30.09.2026
Visipaque 320
Iodixanol
Reported
Reported 30.09.2026
Visipaque 320
Iodixanol
Reported
Reported 29.09.2026
Calci D3-Denk 1000mg/880i.E.
Calciumcarbonat; Colecalciferol
Reported
Reported 29.09.2026
Calci D3-Denk 1000mg/880i.E.
Calciumcarbonat; Colecalciferol
Supply-critical
Reported 29.09.2026
Indometacin AL 50
Indometacin
Supply-critical
Reported 29.09.2026
Indometacin AL 50
Indometacin
Supply-relevant
Hospital-relevant Reported 29.09.2026
Palonosetron Fresenius Kabi 250 Mikrogramm Injektionslösung
Palonosetronhydrochlorid
2 clinical trials →
Reported
Reported 29.09.2026
Scandicain 2 %
Mepivacainhydrochlorid
Reported
Reported 29.09.2026
Scandicain 2 % Fl. 50 ml
Mepivacainhydrochlorid
Reported
Reported 29.09.2026
Scandicain 1 %
Mepivacainhydrochlorid
Reported
Reported 29.09.2026
Scandicain 1% Fl. 50 ml
Mepivacainhydrochlorid
Supply-critical
Reported 29.09.2026
Tacrolimus AL 3 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Reported 29.09.2026
Tacrolimus AL 3 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Reported
Reported 29.09.2026
Tacrolimus AL 0,5 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Reported
Reported 29.09.2026
Tacrolimus AL 0,5 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Reported 29.09.2026
Tacrolimus AL 1 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Reported 29.09.2026
Tacrolimus AL 1 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Reported 29.09.2026
Tacrolimus AL 5 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Reported 29.09.2026
Tacrolimus AL 5 mg Hartkapseln, retardiert
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Reported 29.09.2026
Aggrastat 50 Mikrogramm/ml Infusionslösung
Tirofibanhydrochlorid-Monohydrat
12 clinical trials →
Supply-relevant
Hospital-relevant Reported 28.09.2026
Pantoprazol-Micro Labs 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Hospital-relevant Reported 28.09.2026
Pantoprazol-Micro Labs 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Hospital-relevant Reported 28.09.2026
Pantoprazol-Micro Labs 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Hospital-relevant Reported 28.09.2026
Pantoprazol-Micro Labs 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Hospital-relevant Reported 28.09.2026
Pantoprazol-Micro Labs 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-critical
Reported 28.09.2026
Levosert 20 Mikrogramm/24 Stunden intrauterines Wirkstofffreisetzungssystem
Levonorgestrel
2 clinical trials →
Supply-critical
Hospital-relevant Reported 28.09.2026
Phenhydan Injektionslösung
Phenytoin-Natrium
5 clinical trials →
Supply-critical
Hospital-relevant Reported 28.09.2026
Carboplatin Hikma 10 mg/ml Infusionslösung
Carboplatin
587 clinical trials →
Supply-critical
Hospital-relevant Reported 28.09.2026
Carboplatin Hikma 10 mg/ml Infusionslösung
Carboplatin
587 clinical trials →
Reported
Reported 28.09.2026
Seroquel Prolong 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 25.09.2026
Flurazepam real
Flurazepam
Supply-critical
Reported 25.09.2026
Methofill 50 mg/ml Injektionslösung in einer Fertigspritze
Methotrexat
123 clinical trials →
Supply-critical
Reported 25.09.2026
Methofill 50 mg/ml Injektionslösung in einer Fertigspritze
Methotrexat
123 clinical trials →
Supply-critical
Reported 25.09.2026
Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Oxaloplatin
Reported
Hospital-relevant Reported 25.09.2026
Ropivacainhydrochlorid Kabi 2 mg/ml Injektionslösung
Ropivacainhydrochlorid
36 clinical trials →
Reported
Reported 24.09.2026
EZETIMIB/SIMVA BASICS 10 mg/20 mg Tabletten
Ezetimib; Simvastatin
15 clinical trials →
Reported
Reported 24.09.2026
EZETIMIB/SIMVA BASICS 10 mg/20 mg Tabletten
Ezetimib; Simvastatin
15 clinical trials →
Reported
Reported 24.09.2026
EZETIMIB/SIMVA BASICS 10 mg/10 mg Tabletten
Ezetimib; Simvastatin
15 clinical trials →
Reported
Reported 24.09.2026
EZETIMIB/SIMVA BASICS 10 mg/40 mg Tabletten
Ezetimib; Simvastatin
15 clinical trials →
Reported
Reported 24.09.2026
EZETIMIB/SIMVA BASICS 10 mg/40 mg Tabletten
Ezetimib; Simvastatin
15 clinical trials →
Reported
Reported 24.09.2026
EZETIMIB/SIMVA BASICS 10 mg/80 mg Tabletten
Ezetimib; Simvastatin
15 clinical trials →
Reported
Reported 24.09.2026
Tobramycin SUN 300 mg Lösung für einen Vernebler
Tobramycin
3 clinical trials →
Supply-relevant
Reported 24.09.2026
LEVETIRACETAM BASICS 1000 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 24.09.2026
LEVETIRACETAM BASICS 1000 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 24.09.2026
CIPRO BASICS 250 mg Filmtabletten
Ciprofloxacinhydrochlorid-Monohydrat
12 clinical trials →
Supply-relevant
Reported 24.09.2026
CIPRO BASICS 250 mg Filmtabletten
Ciprofloxacinhydrochlorid-Monohydrat
12 clinical trials →
Supply-critical
Reported 24.09.2026
CEFUROX BASICS 125mg/5 ml Granulat zur Herstellung einer Suspension zum Einnehmen
Cefuroximaxetil
Supply-critical
Reported 24.09.2026
CEFACLOR BASICS 250 mg TS
Cefaclor-Monohydrat
2 clinical trials →
Supply-critical
Reported 24.09.2026
CEFACLOR BASICS 250 mg TS
Cefaclor-Monohydrat
2 clinical trials →
Supply-critical
Reported 24.09.2026
CEFACLOR BASICS 125 mg TS
Cefaclor-Monohydrat
2 clinical trials →
Reported
Hospital-relevant Reported 24.09.2026
NuTRIflex Omega peri novo Emulsion zur Infusion
Alanin; Arginin; Aspartinsäure; Calciumchlorid-Dihydrat; Glucose-Monohydrat (Ph.Eur.); Glutaminsäure; Glycin; Histidinhydrochlorid-Monohydrat; Isoleucin; Kaliumacetat; Leucin; Lysinhydrochlorid; Magnesiumacetat-Tetrahydrat; Methionin; Mittelkettige Triglyceride; Natriumacetat-Trihydrat; Natriumchlorid; Natriumdihydrogenphosphat-Dihydrat; Natriumhydroxid; Omega-3-Säuren-Triglyceride ((mit Angaben zur Herkunft und/oder zur Zusammensetzung)); Phenylalanin; Prolin; Raffiniertes Sojaöl (Ph.Eur.); Serin; Threonin; Tryptophan; Valin; Zinkacetat-Dihydrat
2 clinical trials →
Supply-critical
Reported 24.09.2026
Carboplatin Accord 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Carboplatin
587 clinical trials →
Reported
Reported 24.09.2026
Seroquel Prolong 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 24.09.2026
Seroquel Prolong 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Hospital-relevant Reported 24.09.2026
WILLFACT 1000 I.E.
Von Willebrand-Faktor
Supply-critical
Hospital-relevant Reported 23.09.2026
Teicoplanin Eberth 400 mg Pulver zur Herstellung einer Injektions-/Infusionslösung oder einer Lösung zum Einnehmen
Teicoplanin
2 clinical trials →
Supply-critical
Hospital-relevant Reported 23.09.2026
Teicoplanin Eberth 200 mg Pulver zur Herstellung einer Injektions-/Infusionslösung oder einer Lösung zum Einnehmen
Teicoplanin
2 clinical trials →
Supply-critical
Hospital-relevant Reported 23.09.2026
Fosfomycin Eberth 4 g Pulver zur Herstellung einer Infusionslösung
Fosfomycin-Natrium (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 23.09.2026
Fosfomycin Eberth 2 g Pulver zur Herstellung einer Infusionslösung
Fosfomycin-Natrium (Ph.Eur.)
Reported
Hospital-relevant Reported 23.09.2026
Levomepromazin-neuraxpharm 25 mg/ml Injektionslösung
Levomepromazinhydrochlorid
Reported
Reported 23.09.2026
Vagantin RIEMSER
Methantheliniumbromid
Reported
Reported 23.09.2026
Vagantin RIEMSER
Methantheliniumbromid
Reported
Reported 23.09.2026
Vagantin RIEMSER
Methantheliniumbromid
Supply-relevant
Reported 21.09.2026
Dexa-Ophtal
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.)
Supply-relevant
Reported 21.09.2026
Floxal 3 mg/ml Augentropfen
Ofloxacin
Supply-critical
Reported 21.09.2026
Miochol-E Pulver und Lösungsmittel zur Herstellung einer Instillationslösung zur intraokularen Anwendung
Acetylcholinchlorid
Supply-relevant
Hospital-relevant Reported 21.09.2026
Escitalopram-Micro Labs 15 mg Filmtabletten
Escitalopramoxalat
Supply-relevant
Hospital-relevant Reported 21.09.2026
Escitalopram-Micro Labs 10 mg Filmtabletten
Escitalopramoxalat
Supply-relevant
Hospital-relevant Reported 21.09.2026
Escitalopram-Micro Labs 10 mg Filmtabletten
Escitalopramoxalat
Supply-relevant
Hospital-relevant Reported 21.09.2026
Escitalopram-Micro Labs 10 mg Filmtabletten
Escitalopramoxalat
Supply-critical
Reported 21.09.2026
Dexahexal 4 mg
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.)
Supply-critical
Reported 21.09.2026
Cefuroxim - 1 A Pharma 125 mg/5 ml Granulat zur Herstellung einer Suspension zum Einnehmen
Cefuroximaxetil
Reported
Reported 21.09.2026
BisoHEXAL plus 5/12,5
Bisoprololfumarat (Ph.Eur.); Hydrochlorothiazid
5 clinical trials →
Supply-relevant
Reported 21.09.2026
Abirateron HEXAL 1000 mg Filmtabletten
Abirateronacetat
38 clinical trials →
Supply-relevant
Reported 21.09.2026
Abirateron HEXAL 1000 mg Filmtabletten
Abirateronacetat
38 clinical trials →
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 600 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 600 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 600 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin HEXAL 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 21.09.2026
Quetiapin - 1 A Pharma 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Supply-relevant
Reported 21.09.2026
Oxcarbazepin - 1 A Pharma 60 mg/ml Suspension zum Einnehmen
Oxcarbazepin
Reported
Reported 21.09.2026
Levetiracetam - 1 A Pharma 1500 mg Filmtabletten
Levetiracetam
13 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 60 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 60 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 25 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 25 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 25 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 18 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 10 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 10 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 100 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
Atomoxe - 1 A Pharma 100 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 21.09.2026
MetoHEXAL 200 mg retard
Metoprololtartrat (Ph.Eur.)
Reported
Reported 21.09.2026
MetoHEXAL 200 mg retard
Metoprololtartrat (Ph.Eur.)
Supply-relevant
Reported 21.09.2026
Levetiracetam HEXAL 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Levetiracetam
13 clinical trials →
Reported
Reported 21.09.2026
Bisoprolol plus 5/12,5 - 1 A Pharma
Bisoprololfumarat (Ph.Eur.); Hydrochlorothiazid
5 clinical trials →
Reported
Reported 21.09.2026
Bisoprolol plus 5/12,5 - 1 A Pharma
Bisoprololfumarat (Ph.Eur.); Hydrochlorothiazid
5 clinical trials →
Supply-critical
Reported 18.09.2026
Baqsimi 3 mg Nasenpulver in einem Einzeldosisbehältnis
Glucagon
2 clinical trials →
Reported
Hospital-relevant Reported 18.09.2026
Xenpozyme
Olipudase alfa
Supply-critical
Hospital-relevant Reported 18.09.2026
Valgapan 50 mg/ml Pulver zur Herstellung einer Lösung zum Einnehmen
Valganciclovirhydrochlorid
6 clinical trials →
Supply-critical
Reported 18.09.2026
Presinol 500
Methyldopa (Ph.Eur.)
Reported
Hospital-relevant Reported 18.09.2026
Lanthan Mylan 1000 mg Kautabletten
Lanthan
Reported
Hospital-relevant Reported 18.09.2026
Lanthan Mylan 500 mg Kautabletten
Lanthan
Reported
Reported 18.09.2026
Perindopril-dura plus 4 mg/1,25 mg Tabletten
Indapamid; Perindopril-tert-butylamin
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 18.09.2026
ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml)
Olanzapinembonat-Monohydrat
Supply-relevant
Reported 17.09.2026
Topiramat-Hormosan 50 mg Filmtabletten
Topiramat
4 clinical trials →
Supply-relevant
Hospital-relevant Reported 17.09.2026
Aknenormin 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Hospital-relevant Reported 17.09.2026
Aknenormin 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Hospital-relevant Reported 17.09.2026
Aknenormin 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Hospital-relevant Reported 17.09.2026
Aknenormin 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 17.09.2026
PANTOPRAZOL BASICS 20 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 17.09.2026
PANTOPRAZOL BASICS 20 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 17.09.2026
PANTOPRAZOL BASICS 20 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 17.09.2026
PANTOPRAZOL BASICS 20 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Reported
Reported 17.09.2026
Seroquel Prolong 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 17.09.2026
Seroquel Prolong 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Hospital-relevant Reported 16.09.2026
Solian 400 mg Filmtabletten
Amisulprid
Supply-relevant
Reported 16.09.2026
Urapidil AL 30 mg Hartkapseln, retardiert
Urapidil
Supply-relevant
Reported 16.09.2026
Urapidil AL 30 mg Hartkapseln, retardiert
Urapidil
Supply-critical
Hospital-relevant Reported 15.09.2026
Atgam
Anti-Human-T-Lymphozyten-Immunglobulin vom Pferd
Supply-relevant
Hospital-relevant Reported 15.09.2026
Urapidil Stragen 90 mg retardierte Hartkapseln
Urapidil
Reported
Reported 15.09.2026
Galantamin-neuraxpharm 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 15.09.2026
Galantamin-neuraxpharm 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 15.09.2026
Galantamin-neuraxpharm 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 15.09.2026
Galantamin-neuraxpharm 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 15.09.2026
Galantamin-neuraxpharm 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 15.09.2026
Galantamin-neuraxpharm 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 15.09.2026
Galantamin-neuraxpharm 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 15.09.2026
Flupentixol-neuraxpharm 100 mg/ml
Flupentixoldecanoat
Reported
Reported 15.09.2026
Flupentixol-neuraxpharm 20 mg/ml
Flupentixoldecanoat
Reported
Reported 15.09.2026
Flupentixol-neuraxpharm 40 mg/ml
Flupentixoldecanoat
Supply-relevant
Hospital-relevant Reported 14.09.2026
Urapidil PUREN 90 mg Retardkapseln
Urapidil
Reported
Hospital-relevant Reported 14.09.2026
Staphylex 250 mg Kapseln
Flucloxacillin-Natrium 1 H<2>O
Reported
Hospital-relevant Reported 14.09.2026
Staphylex 250 mg Kapseln
Flucloxacillin-Natrium 1 H<2>O
Supply-critical
Reported 14.09.2026
Amiodaron Aurobindo 200 mg Tabletten
Amiodaronhydrochlorid
5 clinical trials →
Reported
Hospital-relevant Reported 14.09.2026
DOCITON 40mg
Propranololhydrochlorid
24 clinical trials →
Reported
Reported 14.09.2026
bicaNorm
Natriumhydrogencarbonat
Reported
Hospital-relevant Reported 11.09.2026
Mivacron 10mg
Mivacuriumchlorid
Supply-critical
Hospital-relevant Reported 11.09.2026
Fasturtec 1,5 mg Pulver und Lösungsmittel zur Herstellung eines Infusionslösungskonzentrats - OP(3+3)
Rasburicase
Supply-relevant
Reported 10.09.2026
Aciclovir AbZ Lippenherpescreme
Aciclovir
Supply-relevant
Reported 10.09.2026
Isotretinoin-ratiopharm 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 10.09.2026
Isotretinoin-ratiopharm 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 10.09.2026
Isotretinoin-ratiopharm 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 10.09.2026
Isotretinoin-ratiopharm 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 10.09.2026
Isotretinoin-ratiopharm 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 10.09.2026
Isotretinoin-ratiopharm 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.09.2026
Neosynephrin-POS 10%
Phenylephrinhydrochlorid
12 clinical trials →
Supply-relevant
Reported 09.09.2026
Neosynephrin-POS 10%
Phenylephrinhydrochlorid
12 clinical trials →
Supply-critical
Hospital-relevant Reported 09.09.2026
Dexa-inject mibe 10 mg/ml
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 09.09.2026
Dexa-inject mibe 4 mg/ml
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 09.09.2026
Dexa-inject mibe 4 mg/ml
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 09.09.2026
Dexa-inject mibe 4 mg/ml
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.)
Supply-relevant
Reported 08.09.2026
Ritonavir Viatris 100 mg Filmtabletten - OP30
Ritonavir
3 clinical trials →
Supply-relevant
Reported 08.09.2026
Ritonavir Viatris 100 mg Filmtabletten - OP30
Ritonavir
3 clinical trials →
Reported
Reported 08.09.2026
Anatrofer 1000 mg magensaftresistente Tabletten
Natriumhydrogencarbonat
Supply-relevant
Reported 07.09.2026
Urapidil Bluefish 30 mg Hartkapseln, retardiert
Urapidil
Supply-relevant
Reported 07.09.2026
Urapidil Bluefish 90 mg Hartkapseln, retardiert
Urapidil
Supply-relevant
Reported 04.09.2026
Fingolimod Zentiva 0,5 mg Hartkapseln
Fingolimodhydrochlorid
8 clinical trials →
Supply-relevant
Reported 04.09.2026
Fingolimod Zentiva 0,5 mg Hartkapseln
Fingolimodhydrochlorid
8 clinical trials →
Reported
Hospital-relevant Reported 03.09.2026
Ixoten
Trofosfamid
Supply-critical
Hospital-relevant Reported 03.09.2026
Uromitexan Multidose
Mesna
6 clinical trials →
Supply-critical
Hospital-relevant Reported 03.09.2026
Busulfan-ratiopharm 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Busulfan
23 clinical trials →
Reported
Hospital-relevant Reported 03.09.2026
Aminosteril N-Hepa 8%
Acetylcystein; Alanin; Arginin; Essigsäure 99%; Glycin; Histidin; Isoleucin; Leucin; Lysinacetat; Methionin; Phenylalanin; Prolin; Serin; Threonin; Tryptophan; Valin
2 clinical trials →
Reported
Hospital-relevant Reported 03.09.2026
Aminoven infant 10%
Acetylcystein; Alanin; Arginin; Glycin; Histidin; Isoleucin; L-Äpfelsäure; Leucin; Lysinacetat; Methionin; N-Acetyltyrosin (Ph.Eur.); Phenylalanin; Prolin; Serin; Taurin; Threonin; Tryptophan; Valin
2 clinical trials →
Reported
Hospital-relevant Reported 03.09.2026
Aminoven infant 10%
Acetylcystein; Alanin; Arginin; Glycin; Histidin; Isoleucin; L-Äpfelsäure; Leucin; Lysinacetat; Methionin; N-Acetyltyrosin (Ph.Eur.); Phenylalanin; Prolin; Serin; Taurin; Threonin; Tryptophan; Valin
2 clinical trials →
Supply-critical
Hospital-relevant Reported 02.09.2026
Prepidil Gel
Dinoproston
Supply-critical
Reported 02.09.2026
Risperidon - 1 A Pharma 6 mg Filmtabletten
Risperidon
8 clinical trials →
Supply-critical
Reported 02.09.2026
Risperidon - 1 A Pharma 6 mg Filmtabletten
Risperidon
8 clinical trials →
Supply-relevant
Reported 02.09.2026
MetoHEXAL Succ 142,5 mg Retardtabletten
Metoprololsuccinat (Ph.Eur.)
Supply-relevant
Reported 02.09.2026
MetoHEXAL Succ 142,5 mg Retardtabletten
Metoprololsuccinat (Ph.Eur.)
Supply-relevant
Reported 02.09.2026
Levetiracetam Holsten 1000 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 02.09.2026
Levetiracetam Holsten 1000 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 02.09.2026
Levetiracetam Holsten 750 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 02.09.2026
Levetiracetam Holsten 750 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 02.09.2026
Levetiracetam Holsten 750 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-critical
Reported 02.09.2026
ARA-cell 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Cytarabin
117 clinical trials →
Supply-critical
Reported 02.09.2026
ARA-cell 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Cytarabin
117 clinical trials →
Reported
Hospital-relevant Reported 02.09.2026
Thilorbin
Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid
Reported
Reported 01.09.2026
Perindopril/Indapamid-ratiopharm T 2,5 mg/0,625 mg Filmtabletten
Indapamid; Perindopriltosilat
2 clinical trials →
Reported
Reported 01.09.2026
Perindopril/Indapamid-ratiopharm T 2,5 mg/0,625 mg Filmtabletten
Indapamid; Perindopriltosilat
2 clinical trials →
Reported
Hospital-relevant Reported 31.08.2026
Ropivacain HCl B. Braun 2 mg/ml Injektions-/Infusionslösung
Ropivacainhydrochlorid-Monohydrat
36 clinical trials →
Supply-relevant
Hospital-relevant Reported 31.08.2026
Pantoprazol-Micro Labs 20 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Reported
Reported 28.08.2026
Allergospasmin N
Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid
Reported
Reported 28.08.2026
Allergospasmin N
Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid
Reported
Reported 28.08.2026
Allergospasmin N
Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid
Supply-critical
Reported 27.08.2026
IFO-cell 2g Konzentrat zur Herstellung einer Infusionslösung
Ifosfamid
27 clinical trials →
Supply-critical
Reported 27.08.2026
IFO-cell 5 g Konzentrat zur Herstellung einer Infusionslösung
Ifosfamid
27 clinical trials →
Reported
Hospital-relevant Reported 26.08.2026
SMOFlipid 200 mg/ml Emulsion zur Infusion
Mittelkettige Triglyceride; Omega-3-Säuren-reiches Fischöl ((mit Angaben zur Zusammensetzung)); Raffiniertes Olivenöl; Raffiniertes Sojaöl (Ph.Eur.)
Reported
Hospital-relevant Reported 26.08.2026
SMOFlipid 200 mg/ml Emulsion zur Infusion
Mittelkettige Triglyceride; Omega-3-Säuren-reiches Fischöl ((mit Angaben zur Zusammensetzung)); Raffiniertes Olivenöl; Raffiniertes Sojaöl (Ph.Eur.)
Reported
Hospital-relevant Reported 26.08.2026
SMOFlipid 200 mg/ml Emulsion zur Infusion
Mittelkettige Triglyceride; Omega-3-Säuren-reiches Fischöl ((mit Angaben zur Zusammensetzung)); Raffiniertes Olivenöl; Raffiniertes Sojaöl (Ph.Eur.)
Supply-critical
Reported 26.08.2026
Methyldopa STADA 250mg Filmtablette
Methyldopa (Ph.Eur.)
Supply-critical
Reported 26.08.2026
Methyldopa STADA 250mg Filmtablette
Methyldopa (Ph.Eur.)
Supply-critical
Reported 25.08.2026
Pankreatan 40.000 Ph.Eur.-Einheiten
Pankreas-Pulver vom Schwein
Supply-critical
Reported 25.08.2026
Pankreatan 40.000 Ph.Eur.-Einheiten
Pankreas-Pulver vom Schwein
Supply-critical
Reported 25.08.2026
Pankreatan 40.000 Ph.Eur.-Einheiten
Pankreas-Pulver vom Schwein
Reported
Hospital-relevant Reported 21.08.2026
Tera TAD 10mg
Terazosinhydrochlorid-Dihydrat
Reported
Hospital-relevant Reported 21.08.2026
Tera TAD 10mg
Terazosinhydrochlorid-Dihydrat
Reported
Hospital-relevant Reported 21.08.2026
Tera TAD 2mg
Terazosinhydrochlorid-Dihydrat
Reported
Hospital-relevant Reported 21.08.2026
Tera TAD 2mg
Terazosinhydrochlorid-Dihydrat
Reported
Hospital-relevant Reported 21.08.2026
Tera TAD 5mg
Terazosinhydrochlorid-Dihydrat
Reported
Hospital-relevant Reported 21.08.2026
Tera TAD 5mg
Terazosinhydrochlorid-Dihydrat
Supply-relevant
Hospital-relevant Reported 20.08.2026
Atorvastatin Micro Labs 20 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Reported
Hospital-relevant Reported 20.08.2026
Aminoven 10 %
Alanin; Arginin; Glycin; Histidin; Isoleucin; Leucin; Lysinacetat; Methionin; Phenylalanin; Prolin; Serin; Taurin; Threonin; Tryptophan; Tyrosin; Valin
2 clinical trials →
Reported
Hospital-relevant Reported 20.08.2026
Aminoven 10 %
Alanin; Arginin; Glycin; Histidin; Isoleucin; Leucin; Lysinacetat; Methionin; Phenylalanin; Prolin; Serin; Taurin; Threonin; Tryptophan; Tyrosin; Valin
2 clinical trials →
Reported
Reported 20.08.2026
Epipevisone
Econazolnitrat; Triamcinolonacetonid
Reported
Hospital-relevant Reported 19.08.2026
Ropivacainhydrochlorid Kabi 10 mg/ml Injektionslösung
Ropivacainhydrochlorid
36 clinical trials →
Reported
Reported 19.08.2026
Quetiapin Heumann retard 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin Heumann retard 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Galantamin Heumann 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Quetiapin-Hormosan 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 19.08.2026
Quetiapin-Hormosan 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Supply-relevant
Reported 19.08.2026
Levetiracetam-Hormosan 100 mg/ml Lösung zum Einnehmen
Levetiracetam
13 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 19.08.2026
Galantamin Heumann 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 18.08.2026
Atorvastatin Micro Labs 30 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Hospital-relevant Reported 18.08.2026
Atorvastatin Micro Labs 30 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Hospital-relevant Reported 18.08.2026
Atorvastatin Micro Labs 30 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Reported
Reported 18.08.2026
Eletrip-Hormosan 40 mg Filmtabletten
Eletriptanhydrobromid
Reported
Reported 18.08.2026
Eletrip-Hormosan 20 mg Filmtabletten
Eletriptanhydrobromid
Reported
Reported 18.08.2026
Eletrip-Hormosan 20 mg Filmtabletten
Eletriptanhydrobromid
Supply-critical
Hospital-relevant Reported 18.08.2026
Mitem 20mg
Mitomycin
Supply-critical
Hospital-relevant Reported 18.08.2026
Mitem 20mg
Mitomycin
Supply-critical
Hospital-relevant Reported 18.08.2026
Mitem 20mg
Mitomycin
Reported
Hospital-relevant Reported 17.08.2026
Sertralin TAD 50 mg Filmtabletten
Sertralinhydrochlorid
12 clinical trials →
Reported
Hospital-relevant Reported 17.08.2026
Sertralin TAD 50 mg Filmtabletten
Sertralinhydrochlorid
12 clinical trials →
Reported
Hospital-relevant Reported 17.08.2026
Sertralin TAD 50 mg Filmtabletten
Sertralinhydrochlorid
12 clinical trials →
Reported
Hospital-relevant Reported 17.08.2026
Sertralin TAD 100 mg Filmtabletten
Sertralinhydrochlorid
12 clinical trials →
Reported
Hospital-relevant Reported 17.08.2026
Sertralin TAD 100 mg Filmtabletten
Sertralinhydrochlorid
12 clinical trials →
Reported
Hospital-relevant Reported 17.08.2026
Sertralin TAD 100 mg Filmtabletten
Sertralinhydrochlorid
12 clinical trials →
Supply-relevant
Hospital-relevant Reported 17.08.2026
Atorvastatin Micro Labs 10 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Reported
Reported 14.08.2026
Tarka 240 mg/4 mg Tabletten mit veränderter Wirkstofffreisetzung
Trandolapril; Verapamilhydrochlorid
5 clinical trials →
Reported
Hospital-relevant Reported 12.08.2026
DHC Ennogen 90 mg Retardtabletten
Dihydrocodein[(R,R)-tartrat]
Supply-relevant
Hospital-relevant Reported 12.08.2026
Entecavir Amarox 0,5 mg Filmtabletten
Entecavir
11 clinical trials →
Supply-relevant
Hospital-relevant Reported 12.08.2026
Entecavir Amarox 0,5 mg Filmtabletten
Entecavir
11 clinical trials →
Reported
Reported 11.08.2026
Prednicarbat acis Lösung
Prednicarbat
Reported
Reported 11.08.2026
Neotri
Triamteren; Xipamid
Supply-critical
Hospital-relevant Reported 10.08.2026
Cefotaxim-saar 1 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
Cefotaxim-Natrium
2 clinical trials →
Supply-critical
Hospital-relevant Reported 10.08.2026
Cefotaxim-saar 2 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
Cefotaxim-Natrium
2 clinical trials →
Supply-critical
Hospital-relevant Reported 07.08.2026
DRIPONIN 3 mg Tabletten
Ivermectin
3 clinical trials →
Supply-relevant
Hospital-relevant Reported 07.08.2026
Dabigatranetexilat Viatris 110 mg Hartkapseln
Dabigatranetexilatmesilat
Supply-relevant
Hospital-relevant Reported 07.08.2026
Dabigatranetexilat Viatris 110 mg Hartkapseln
Dabigatranetexilatmesilat
Supply-relevant
Hospital-relevant Reported 07.08.2026
Dabigatranetexilat Viatris 110 mg Hartkapseln
Dabigatranetexilatmesilat
Supply-relevant
Hospital-relevant Reported 07.08.2026
Dabigatranetexilat Viatris 75 mg Hartkapseln
Dabigatranetexilatmesilat
Supply-relevant
Reported 06.08.2026
Gabapentin Holsten 100 mg Hartkapseln
Gabapentin
11 clinical trials →
Supply-relevant
Reported 06.08.2026
Gabapentin Holsten 100 mg Hartkapseln
Gabapentin
11 clinical trials →
Supply-relevant
Reported 06.08.2026
Gabapentin Holsten 100 mg Hartkapseln
Gabapentin
11 clinical trials →
Reported
Reported 06.08.2026
Quetiapin Accord 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 06.08.2026
Quetiapin Accord 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 06.08.2026
Quetiapin Accord 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 05.08.2026
Plerixafor Viatris 20 mg/ml Injektionslösung
Plerixafor
Reported
Reported 04.08.2026
ROSUVASTATIN-ELPEN 5 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 04.08.2026
ROSUVASTATIN-ELPEN 5 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 04.08.2026
ROSUVASTATIN-ELPEN 10 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 04.08.2026
ROSUVASTATIN-ELPEN 10 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 04.08.2026
ROSUVASTATIN-ELPEN 20 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 04.08.2026
ROSUVASTATIN-ELPEN 20 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 04.08.2026
ROSUVASTATIN-ELPEN 40 mg Filmtabletten
Rosuvastatin-Hemicalcium
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 70 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 70 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin AWD Matrix 70 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Digitoxin AWD 0,07
Digitoxin
Supply-critical
Reported 04.08.2026
Digitoxin AWD 0,07
Digitoxin
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 52,5 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Reported
Reported 04.08.2026
Galantamin-ratiopharm 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 04.08.2026
Galantamin-ratiopharm 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 04.08.2026
Galantamin-ratiopharm 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Supply-critical
Hospital-relevant Reported 03.08.2026
Hydromorphon PAINBREAK 8 mg Retardtabletten
Hydromorphonhydrochlorid
2 clinical trials →
Supply-critical
Hospital-relevant Reported 03.08.2026
Hydromorphon PAINBREAK 4 mg Retardtabletten
Hydromorphonhydrochlorid
2 clinical trials →
Supply-critical
Hospital-relevant Reported 03.08.2026
Hydromorphon PAINBREAK 24 mg Retardtabletten
Hydromorphonhydrochlorid
2 clinical trials →
Supply-critical
Hospital-relevant Reported 03.08.2026
Hydromorphon PAINBREAK 24 mg Retardtabletten
Hydromorphonhydrochlorid
2 clinical trials →
Supply-critical
Hospital-relevant Reported 03.08.2026
Hydromorphon PAINBREAK 16 mg Retardtabletten
Hydromorphonhydrochlorid
2 clinical trials →
Supply-critical
Hospital-relevant Reported 03.08.2026
Hydromorphon PAINBREAK 16 mg Retardtabletten
Hydromorphonhydrochlorid
2 clinical trials →
Supply-relevant
Reported 03.08.2026
Neosynephrin-POS 5%
Phenylephrinhydrochlorid
12 clinical trials →
Reported
Reported 03.08.2026
Fluoropos
Fluorometholon
Supply-relevant
Hospital-relevant Reported 31.07.2026
Entecavir Amarox 1 mg Filmtabletten
Entecavir
11 clinical trials →
Supply-relevant
Hospital-relevant Reported 31.07.2026
Entecavir Amarox 1 mg Filmtabletten
Entecavir
11 clinical trials →
Supply-critical
Reported 31.07.2026
Bendarabin 50 mg
Fludarabinphosphat (Ph.Eur.)
Supply-critical
Reported 31.07.2026
Bendarabin 50 mg
Fludarabinphosphat (Ph.Eur.)
Reported
Reported 30.07.2026
ESOMEPRAZOL BASICS 20 mg magensaftresistente Tabletten
Esomeprazol-Hemimagnesium
Reported
Reported 30.07.2026
ESOMEPRAZOL BASICS 20 mg magensaftresistente Tabletten
Esomeprazol-Hemimagnesium
Reported
Reported 30.07.2026
ESOMEPRAZOL BASICS 20 mg magensaftresistente Tabletten
Esomeprazol-Hemimagnesium
Reported
Reported 29.07.2026
Sultiam-neuraxpharm 50 mg Filmtabletten
Sultiam
Reported
Reported 29.07.2026
Sultiam-neuraxpharm 50 mg Filmtabletten
Sultiam
Reported
Reported 29.07.2026
Sultiam-neuraxpharm 100 mg Filmtabletten
Sultiam
Reported
Reported 29.07.2026
Sultiam-neuraxpharm 100 mg Filmtabletten
Sultiam
Reported
Reported 28.07.2026
Dexa-Gentamicin
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.); Gentamicinsulfat
6 clinical trials →
Supply-critical
Hospital-relevant Reported 27.07.2026
Idarubicin Hikma 1 mg/ml Injektionslösung
Idarubicinhydrochlorid
15 clinical trials →
Supply-relevant
Reported 24.07.2026
D3-Vicotrat
Colecalciferol
Supply-critical
Reported 23.07.2026
NIPRUSS
Dinatrium-pentacyanonitrosylferrat(2-)
Supply-relevant
Hospital-relevant Reported 23.07.2026
Carmustin-ratiopharm
Carmustin
Supply-critical
Hospital-relevant Reported 23.07.2026
Melphalan-ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Injektions- bzw. Infusionslösung
Melphalanhydrochlorid
32 clinical trials →
Reported
Hospital-relevant Reported 21.07.2026
Brevibloc 10 mg/ml Infusionslösung
Esmololhydrochlorid
6 clinical trials →
Supply-relevant
Reported 21.07.2026
Pantoprazol Denk 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 21.07.2026
Pantoprazol Denk 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Supply-relevant
Reported 21.07.2026
Pantoprazol Denk 40 mg magensaftresistente Tabletten
Pantoprazol-Natrium-Sesquihydrat
Reported
Hospital-relevant Reported 20.07.2026
Urbason solubile forte 1000 mg
Natrium(methylprednisolon-21-succinat)
Reported
Hospital-relevant Reported 20.07.2026
Urbason solubile forte 1000 mg
Natrium(methylprednisolon-21-succinat)
Reported
Reported 20.07.2026
Actos 15 mg Tabletten - OP112
Pioglitazonhydrochlorid
14 clinical trials →
Reported
Reported 20.07.2026
Quetiapin Glenmark 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Quetiapin Glenmark 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.07.2026
Galantamin Glenmark 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 20.07.2026
Galantamin Glenmark 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Supply-critical
Reported 15.07.2026
Fluorescein Alcon 10%
Fluorescein-Natrium (Ph.Eur.)
Supply-relevant
Hospital-relevant Reported 14.07.2026
Etoricoxib PUREN 90 mg Filmtabletten
Etoricoxib
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 14.07.2026
Etoricoxib PUREN 90 mg Filmtabletten
Etoricoxib
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 14.07.2026
Etoricoxib PUREN 90 mg Filmtabletten
Etoricoxib
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 14.07.2026
Etoricoxib PUREN 120 mg Filmtabletten
Etoricoxib
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 14.07.2026
Etoricoxib PUREN 30 mg Filmtabletten
Etoricoxib
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 14.07.2026
Sumatriptan Aurobindo 100 mg Tabletten
Sumatriptansuccinat
2 clinical trials →
Supply-relevant
Hospital-relevant Reported 14.07.2026
Escitalopram Aurobindo 10 mg Filmtabletten
Escitalopramoxalat
Reported
Reported 14.07.2026
Perindopril/Amlodipin Denk 4 mg/10 mg Tabletten
Amlodipinbesilat; Perindopril-tert-butylamin
10 clinical trials →
Supply-critical
Reported 13.07.2026
Idarubicin HEXAL 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Idarubicinhydrochlorid
15 clinical trials →
Reported
Reported 09.07.2026
Tolterodin-Aristo 1 mg Filmtabletten
Tolterodintartrat
2 clinical trials →
Supply-critical
Reported 09.07.2026
Victoza 6 mg/ml Injektionslösung in Fertigpen - OP(2x3ml)
Liraglutid
8 clinical trials →
Supply-relevant
Hospital-relevant Reported 07.07.2026
Dorzo-Vision sine 20 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis
Dorzolamidhydrochlorid
Supply-relevant
Hospital-relevant Reported 07.07.2026
Dorzo-Vision sine 20 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis
Dorzolamidhydrochlorid
Supply-critical
Reported 07.07.2026
Tacpan 5 mg Hartkapseln
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Reported 07.07.2026
Tacpan 5 mg Hartkapseln
Tacrolimus-Monohydrat
46 clinical trials →
Supply-critical
Hospital-relevant Reported 07.07.2026
Metalcaptase 150 mg
Penicillamin
Supply-critical
Hospital-relevant Reported 07.07.2026
Metalcaptase 150 mg
Penicillamin
Reported
Hospital-relevant Reported 07.07.2026
Lanthan Mylan 750 mg Kautabletten
Lanthan
Reported
Hospital-relevant Reported 06.07.2026
Custodiol
Calciumchlorid-Dihydrat; Histidin; Histidinhydrochlorid-Monohydrat; Kalium-hydrogen-2-oxopentandioat; Kaliumchlorid; Magnesiumchlorid-Hexahydrat; Mannitol (Ph.Eur.); Natriumchlorid; Tryptophan
Reported
Hospital-relevant Reported 06.07.2026
Custodiol
Calciumchlorid-Dihydrat; Histidin; Histidinhydrochlorid-Monohydrat; Kalium-hydrogen-2-oxopentandioat; Kaliumchlorid; Magnesiumchlorid-Hexahydrat; Mannitol (Ph.Eur.); Natriumchlorid; Tryptophan
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 160 mg/12,5 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 160 mg/12,5 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 160 mg/12,5 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Supply-relevant
Reported 03.07.2026
Bendarelbin 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Vinorelbintartrat
41 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Reported
Reported 03.07.2026
VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten
Hydrochlorothiazid; Valsartan
5 clinical trials →
Supply-relevant
Hospital-relevant Reported 02.07.2026
Adenosin Altamedics 3 mg/ml Injektionslösung
Adenosin
2 clinical trials →
Reported
Hospital-relevant Reported 02.07.2026
Adenosin Altamedics 30 mg/10 ml Infusionslösung
Adenosin
2 clinical trials →
Reported
Reported 02.07.2026
Quetiapin Accord 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.07.2026
Quetiapin Accord 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.07.2026
Quetiapin Accord 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 30.06.2026
Galanaxiro 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 24 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 16 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Reported
Reported 30.06.2026
Galanaxiro 8 mg Hartkapseln, retardiert
Galantaminhydrobromid
2 clinical trials →
Supply-relevant
Reported 29.06.2026
Levetiracetam Holsten 500 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 29.06.2026
Levetiracetam Holsten 500 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 23.06.2026
Kanamycin-POS
Kanamycinmonosulfat (Ph.Eur.)
Supply-relevant
Reported 23.06.2026
Kanamycin-POS
Kanamycinmonosulfat (Ph.Eur.)
Supply-relevant
Reported 23.06.2026
Doxepin 75 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-relevant
Reported 23.06.2026
Doxepin 75 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-relevant
Reported 23.06.2026
Doxepin 75 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-relevant
Reported 23.06.2026
Doxepin 25 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-relevant
Reported 23.06.2026
Doxepin 25 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-relevant
Reported 23.06.2026
Doxepin 25 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 23.06.2026
Minprostin E2 Vaginalgel 1mg
Dinoproston
Supply-critical
Hospital-relevant Reported 23.06.2026
Ampicillin/Sulbactam PUREN 2000 mg/1000 mg Pulver zur Herstellung einer Infusionslösung
Ampicillin-Natrium; Sulbactam-Natrium
3 clinical trials →
Supply-relevant
Hospital-relevant Reported 23.06.2026
Teriflunomid PUREN 14 mg Filmtabletten
Teriflunomid
7 clinical trials →
Supply-relevant
Hospital-relevant Reported 23.06.2026
Escitalopram Aurobindo 20 mg Filmtabletten
Escitalopramoxalat
Supply-relevant
Hospital-relevant Reported 23.06.2026
Entecavir PUREN 0,5 mg Filmtabletten
Entecavir-Monohydrat
11 clinical trials →
Supply-critical
Hospital-relevant Reported 23.06.2026
Cefixim AL 100 mg/5 ml Pulver zur Herstellung einer Suspension zum Einnehmen
Cefixim 3 H<2>O
Supply-critical
Hospital-relevant Reported 23.06.2026
Cefixim AL 100 mg/5 ml Pulver zur Herstellung einer Suspension zum Einnehmen
Cefixim 3 H<2>O
Supply-critical
Hospital-relevant Reported 23.06.2026
Cefixim AL 100 mg/5 ml Pulver zur Herstellung einer Suspension zum Einnehmen
Cefixim 3 H<2>O
Supply-critical
Reported 22.06.2026
Levosert One 20 Mikrogramm/24 Stunden intrauterines Wirkstofffreisetzungssystem
Levonorgestrel
2 clinical trials →
Supply-critical
Reported 17.06.2026
Risperidon Mylan 1 mg Filmtabletten
Risperidon
8 clinical trials →
Supply-critical
Reported 17.06.2026
Risperidon Mylan 3 mg Filmtabletten
Risperidon
8 clinical trials →
Supply-critical
Reported 17.06.2026
Risperidon Mylan 2 mg Filmtabletten
Risperidon
8 clinical trials →
Supply-critical
Reported 17.06.2026
Risperidon Mylan 4 mg Filmtabletten
Risperidon
8 clinical trials →
Supply-critical
Hospital-relevant Reported 17.06.2026
Emblaveo
Avibactam-Natrium; Aztreonam
4 clinical trials →
Supply-relevant
Reported 16.06.2026
Aprepitant Zentiva 80 mg und 125 mg Hartkapseln
Aprepitant
5 clinical trials →
Supply-critical
Hospital-relevant Reported 16.06.2026
Dexamethason 1,5 mg Jenapharm
Dexamethason
342 clinical trials →
Supply-relevant
Hospital-relevant Reported 15.06.2026
Prostavasin 20 µg
Alprostadil
Supply-critical
Reported 11.06.2026
Skid 100mg
Minocyclinhydrochlorid-Dihydrat (Ph.Eur.)
Reported
Hospital-relevant Reported 08.06.2026
Bronchitol 40 mg Hartkapsel mit Pulver zur Inhalation - OP10(1x10)
Mannitol (Ph.Eur.)
Supply-relevant
Reported 05.06.2026
ATORVASTATIN BASICS 30 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 03.06.2026
Oxytocin 5 I.E. Hexal
Oxytocin
21 clinical trials →
Supply-relevant
Hospital-relevant Reported 02.06.2026
Cisatracurium-hameln 2 mg/ml Injektionslösung/Infusionslösung
Cisatracuriumbesilat
3 clinical trials →
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 150 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 200 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 300 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 600 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 600 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.06.2026
Quetiapin-neuraxpharm 600 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 20.05.2026
Calcium-EAP
(2-Aminoethyl)dihydrogenphosphat-Calciumsalz (1:1)
Reported
Reported 20.05.2026
Calcium-EAP
(2-Aminoethyl)dihydrogenphosphat-Calciumsalz (1:1)
Reported
Reported 13.05.2026
Seroquel Prolong 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 13.05.2026
Seroquel Prolong 50 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 11.05.2026
Diltiazem AbZ 90mg Retardtabletten
Diltiazemhydrochlorid
2 clinical trials →
Reported
Reported 11.05.2026
Diltiazem AbZ 60 mg Tabletten
Diltiazemhydrochlorid
2 clinical trials →
Reported
Reported 11.05.2026
Diltiazem-ratiopharm 60 mg Tabletten
Diltiazemhydrochlorid
2 clinical trials →
Reported
Reported 07.05.2026
Paliperidon Advanz Pharma 150 mg Depot-Injektionssuspension in einer Fertigspritze
Paliperidonpalmitat
Reported
Reported 07.05.2026
Paliperidon Advanz Pharma 100 mg Depot-Injektionssuspension in einer Fertigspritze
Paliperidonpalmitat
Reported
Reported 07.05.2026
Paliperidon Advanz Pharma 25 mg Depot-Injektionssuspension in einer Fertigspritze
Paliperidonpalmitat
Reported
Reported 07.05.2026
Paliperidon Advanz Pharma 50 mg Depot-Injektionssuspension in einer Fertigspritze
Paliperidonpalmitat
Reported
Reported 07.05.2026
Paliperidon Advanz Pharma 75 mg Depot-Injektionssuspension in einer Fertigspritze
Paliperidonpalmitat
Reported
Reported 07.05.2026
ESOMEPRAZOL BASICS 40 mg magensaftresistente Tabletten
Esomeprazol-Hemimagnesium
Reported
Reported 07.05.2026
ESOMEPRAZOL BASICS 40 mg magensaftresistente Tabletten
Esomeprazol-Hemimagnesium
Reported
Reported 07.05.2026
ESOMEPRAZOL BASICS 40 mg magensaftresistente Tabletten
Esomeprazol-Hemimagnesium
Supply-relevant
Reported 04.05.2026
Ubretid Tabletten
Distigminbromid
Supply-relevant
Reported 04.05.2026
Ubretid Tabletten
Distigminbromid
Reported
Reported 04.05.2026
Scintimun
Besilesomab
Supply-critical
Reported 04.05.2026
Dexafluid 1 mg/ml Augentropfen
Dexamethasondihydrogenphosphat-Dinatrium (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 24.04.2026
Tardocillin 1200
Benzylpenicillin-Benzathin-Tetrahydrat (Ph.Eur.) ((mit Angaben zum Dispergier- oder Suspendiermittel))
Supply-critical
Hospital-relevant Reported 24.04.2026
Tardocillin 1200
Benzylpenicillin-Benzathin-Tetrahydrat (Ph.Eur.) ((mit Angaben zum Dispergier- oder Suspendiermittel))
Supply-critical
Hospital-relevant Reported 24.04.2026
Tardocillin 1200
Benzylpenicillin-Benzathin-Tetrahydrat (Ph.Eur.) ((mit Angaben zum Dispergier- oder Suspendiermittel))
Supply-relevant
Reported 22.04.2026
Dabigatranetexilat Viatris 150 mg Hartkapseln
Dabigatranetexilatmesilat
Supply-relevant
Reported 22.04.2026
Dabigatranetexilat Viatris 150 mg Hartkapseln
Dabigatranetexilatmesilat
Reported
Reported 16.04.2026
Seroquel Prolong 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 16.04.2026
Seroquel Prolong 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 10.04.2026
INFECTOMYCIN 600 Saft
Erythromycinestolat
Supply-relevant
Hospital-relevant Reported 10.04.2026
Atosil Injektionslösung N
Promethazinhydrochlorid
Reported
Hospital-relevant Reported 10.04.2026
Neurocil Ampullen
Levomepromazinhydrochlorid
Reported
Hospital-relevant Reported 10.04.2026
Glianimon 2 ml
Benperidol
Supply-relevant
Reported 09.04.2026
LEVETIRACETAM BASICS 750 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 09.04.2026
LEVETIRACETAM BASICS 250 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 09.04.2026
LEVETIRACETAM BASICS 250 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 09.04.2026
LEVETIRACETAM BASICS 250 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 20 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Supply-relevant
Reported 09.04.2026
ISOTRETINOIN BASICS 10 mg Weichkapseln
Isotretinoin
10 clinical trials →
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 40 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 40 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 40 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 40 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 20 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 20 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 20 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
ESOMEPRAZOL BASICS 20 mg magensaftresistente Hartkapseln
Esomeprazol-Hemimagnesium
Reported
Reported 09.04.2026
CANDESARTAN BASICS 4 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 4 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 4 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 32 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 32 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 32 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 16 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 16 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 16 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 8 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 8 mg Tabletten
Candesartancilexetil
Reported
Reported 09.04.2026
CANDESARTAN BASICS 8 mg Tabletten
Candesartancilexetil
Supply-relevant
Reported 09.04.2026
ATORVASTATIN BASICS 60 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Reported 09.04.2026
ATORVASTATIN BASICS 60 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Reported 09.04.2026
ATORVASTATIN BASICS 60 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Hospital-relevant Reported 08.04.2026
Cyclocaps Salbutamol 400 µg
Salbutamolsulfat
4 clinical trials →
Reported
Hospital-relevant Reported 08.04.2026
Cyclocaps Budesonid 200 µg
Budesonid
12 clinical trials →
Reported
Hospital-relevant Reported 08.04.2026
Cyclocaps Budesonid 200 µg
Budesonid
12 clinical trials →
Reported
Hospital-relevant Reported 08.04.2026
Cyclocaps Budesonid 200 µg
Budesonid
12 clinical trials →
Supply-relevant
Hospital-relevant Reported 08.04.2026
Cyclocaps Beclometason 200 µg
Beclometasondipropionat (Ph.Eur.)
Supply-relevant
Hospital-relevant Reported 08.04.2026
Cyclocaps Beclometason 200 µg
Beclometasondipropionat (Ph.Eur.)
Supply-relevant
Hospital-relevant Reported 08.04.2026
Cyclocaps Beclometason 400 µg
Beclometasondipropionat (Ph.Eur.)
Reported
Reported 31.03.2026
Mytolac 60 mg Injektionslösung in einer Fertigspritze
Lanreotidacetat (1:x) ((mit Angaben zum Essigsäure-Gehalt))
Reported
Reported 31.03.2026
Mytolac 60 mg Injektionslösung in einer Fertigspritze
Lanreotidacetat (1:x) ((mit Angaben zum Essigsäure-Gehalt))
Reported
Reported 26.03.2026
Muse 1000 mikrogramm
Alprostadil
Reported
Reported 26.03.2026
Muse 1000 mikrogramm
Alprostadil
Reported
Reported 26.03.2026
Muse 1000 mikrogramm
Alprostadil
Reported
Reported 26.03.2026
Muse 500 mikrogramm
Alprostadil
Reported
Reported 26.03.2026
Muse 500 mikrogramm
Alprostadil
Reported
Reported 26.03.2026
Muse 500 mikrogramm
Alprostadil
Supply-relevant
Reported 25.03.2026
Nifedipin STADA uno 40 mg Retardtabletten
Nifedipin
3 clinical trials →
Supply-relevant
Reported 24.03.2026
Takrozem 1 mg/g Salbe
Tacrolimus-Monohydrat
46 clinical trials →
Supply-relevant
Reported 24.03.2026
Takrozem 1 mg/g Salbe
Tacrolimus-Monohydrat
46 clinical trials →
Supply-relevant
Reported 24.03.2026
Takrozem 1 mg/g Salbe
Tacrolimus-Monohydrat
46 clinical trials →
Supply-relevant
Reported 12.03.2026
Dontisolon D Mundheilpaste
Prednisolonacetat
77 clinical trials →
Supply-relevant
Reported 12.03.2026
Dontisolon D Mundheilpaste
Prednisolonacetat
77 clinical trials →
Reported
Reported 03.03.2026
Heitrin 2mg
Terazosinhydrochlorid-Dihydrat
Reported
Reported 03.03.2026
Heitrin 2mg
Terazosinhydrochlorid-Dihydrat
Reported
Reported 26.02.2026
Eletriptan Bluefish 20 mg Filmtabletten
Eletriptanhydrobromid
Reported
Reported 25.02.2026
Rosuvastatin Aristo 5 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 25.02.2026
Rosuvastatin Aristo 5 mg Filmtabletten
Rosuvastatin-Hemicalcium
Supply-relevant
Hospital-relevant Reported 24.02.2026
Tranexamsäure PUREN 100 mg/ml Injektionslösung
Tranexamsäure
Reported
Reported 23.02.2026
DOXO-cell 150 mg Injektionslösung
Doxorubicinhydrochlorid
153 clinical trials →
Reported
Reported 23.02.2026
DOXO-cell 50 mg Injektionslösung
Doxorubicinhydrochlorid
153 clinical trials →
Reported
Reported 16.02.2026
Heitrin 1mg
Terazosinhydrochlorid-Dihydrat
Reported
Reported 16.02.2026
Heitrin 5mg
Terazosinhydrochlorid-Dihydrat
Reported
Reported 11.02.2026
Supertendin 5
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Reported
Reported 11.02.2026
Supertendin 5
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Reported
Reported 11.02.2026
Supertendin 5
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Reported
Reported 11.02.2026
Supertendin 5
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Reported
Reported 11.02.2026
Supertendin 10
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Reported
Reported 11.02.2026
Supertendin 10
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Reported
Reported 11.02.2026
Supertendin 10
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Reported
Reported 11.02.2026
Supertendin 10
Dexamethasonacetat (Ph.Eur.); Lidocainhydrochlorid-Monohydrat
58 clinical trials →
Supply-relevant
Reported 04.02.2026
Gabapentin Holsten 600 mg Filmtabletten
Gabapentin
11 clinical trials →
Supply-relevant
Reported 04.02.2026
Gabapentin Holsten 600 mg Filmtabletten
Gabapentin
11 clinical trials →
Supply-relevant
Reported 04.02.2026
Gabapentin Holsten 600 mg Filmtabletten
Gabapentin
11 clinical trials →
Supply-critical
Hospital-relevant Reported 03.02.2026
Erwinase 10 000 E./Durchstechflasche Pulver zur Herstellung einer Injektions-/Infusionslösung
Crisantaspase
Supply-relevant
Reported 03.02.2026
Renatriol 0,25 µg
Calcitriol
Supply-relevant
Reported 03.02.2026
Renatriol 0,25 µg
Calcitriol
Supply-relevant
Reported 03.02.2026
Calcitriol KyraMed 0,25 Mikrogramm
Calcitriol
Supply-relevant
Reported 03.02.2026
Calcitriol KyraMed 0,25 Mikrogramm
Calcitriol
Supply-relevant
Reported 27.01.2026
Duloxetin Zentiva 30 mg magensaftresistente Hartkapseln
Duloxetinhydrochlorid
17 clinical trials →
Supply-relevant
Reported 27.01.2026
Duloxetin Zentiva 30 mg magensaftresistente Hartkapseln
Duloxetinhydrochlorid
17 clinical trials →
Supply-relevant
Reported 27.01.2026
Duloxetin Zentiva 30 mg magensaftresistente Hartkapseln
Duloxetinhydrochlorid
17 clinical trials →
Supply-relevant
Reported 27.01.2026
Duloxetin Zentiva 60 mg magensaftresistente Hartkapseln
Duloxetinhydrochlorid
17 clinical trials →
Supply-relevant
Reported 27.01.2026
Duloxetin Zentiva 60 mg magensaftresistente Hartkapseln
Duloxetinhydrochlorid
17 clinical trials →
Supply-relevant
Reported 27.01.2026
Duloxetin Zentiva 60 mg magensaftresistente Hartkapseln
Duloxetinhydrochlorid
17 clinical trials →
Supply-relevant
Reported 27.01.2026
Duloxetin Zentiva 60 mg magensaftresistente Hartkapseln
Duloxetinhydrochlorid
17 clinical trials →
Supply-relevant
Hospital-relevant Reported 27.01.2026
Doxepin 50 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-relevant
Hospital-relevant Reported 27.01.2026
Doxepin 50 Holsten
Doxepinhydrochlorid (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 200 mg
Cyclophosphamid Monohydrat
399 clinical trials →
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 200 mg
Cyclophosphamid Monohydrat
399 clinical trials →
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 500 mg
Cyclophosphamid Monohydrat
399 clinical trials →
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 500 mg
Cyclophosphamid Monohydrat
399 clinical trials →
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 500 mg
Cyclophosphamid Monohydrat
399 clinical trials →
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 1 g
Cyclophosphamid Monohydrat
399 clinical trials →
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 1 g
Cyclophosphamid Monohydrat
399 clinical trials →
Supply-critical
Hospital-relevant Reported 21.01.2026
Endoxan 1 g
Cyclophosphamid Monohydrat
399 clinical trials →
Reported
Reported 16.01.2026
Nitrendipin Aristo 20 mg Filmtabletten
Nitrendipin
Reported
Reported 16.01.2026
Nitrendipin Aristo 20 mg Filmtabletten
Nitrendipin
Reported
Reported 16.01.2026
Nitrendipin Aristo 20 mg Filmtabletten
Nitrendipin
Reported
Reported 16.01.2026
OsvaRen
Calciumacetat; Schweres, basisches Magnesiumcarbonat
3 clinical trials →
Reported
Reported 13.01.2026
Urbason solubile forte 250 mg
Natrium(methylprednisolon-21-succinat)
Reported
Reported 13.01.2026
Urbason solubile forte 250 mg
Natrium(methylprednisolon-21-succinat)
Reported
Reported 13.01.2026
Urbason solubile forte 250 mg
Natrium(methylprednisolon-21-succinat)
Supply-relevant
Reported 13.01.2026
Levetiracetam Holsten 250 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 13.01.2026
Levetiracetam Holsten 250 mg Filmtabletten
Levetiracetam
13 clinical trials →
Supply-relevant
Reported 13.01.2026
Levetiracetam Holsten 250 mg Filmtabletten
Levetiracetam
13 clinical trials →
Reported
Hospital-relevant Reported 11.01.2026
FibCLOT
Fibrinogen vom Menschen
Reported
Hospital-relevant Reported 08.01.2026
Kirsty 100 Einheiten/ml Injektionslösung im Fertigpen
Insulin aspart
3 clinical trials →
Reported
Hospital-relevant Reported 08.01.2026
Kirsty 100 Einheiten/ml Injektionslösung im Fertigpen
Insulin aspart
3 clinical trials →
Reported
Reported 07.01.2026
Doxorubicinhydrochlorid Bendalis 2 mg/ml
Doxorubicinhydrochlorid
153 clinical trials →
Supply-critical
Hospital-relevant Reported 07.01.2026
Somatostatin 3 mg Inresa
Somatostatinacetat
4 clinical trials →
Supply-critical
Hospital-relevant Reported 07.01.2026
Somatostatin 3 mg Inresa
Somatostatinacetat
4 clinical trials →
Supply-critical
Hospital-relevant Reported 05.01.2026
Antidotum Thallii-Heyl
Eisen(III)-hexacyanoferrat(II)
Supply-relevant
Hospital-relevant Reported 02.01.2026
OncoTICE
BCG-Bakterien, Stamm TICE, lebend, attenuiert
Supply-relevant
Hospital-relevant Reported 02.01.2026
OncoTICE
BCG-Bakterien, Stamm TICE, lebend, attenuiert
Supply-critical
Hospital-relevant Reported 10.12.2025
Hydrocortison PANPHARMA 100 mg
Natrium(hydrocortison-21-succinat)
Reported
Reported 10.12.2025
Blopress 16 mg
Candesartancilexetil
Reported
Hospital-relevant Reported 05.12.2025
Ipratropiumbromid 250 Mikrogramm / 1 ml Stulln
Ipratropiumbromid
Reported
Hospital-relevant Reported 03.12.2025
Bendamustin beta 180 mg/4 ml Konzentrat zur Herstellung einer Infusionslösung
Bendamustinhydrochlorid-Monohydrat
53 clinical trials →
Reported
Reported 02.12.2025
Metypred forte 1000mg GALEN
Natrium(methylprednisolon-21-succinat)
Reported
Reported 02.12.2025
Metypred forte 1000mg GALEN
Natrium(methylprednisolon-21-succinat)
Reported
Reported 02.12.2025
Metypred forte 1000mg GALEN
Natrium(methylprednisolon-21-succinat)
Reported
Reported 02.12.2025
Metypred 250mg GALEN
Natrium(methylprednisolon-21-succinat)
Reported
Reported 02.12.2025
Metypred 250mg GALEN
Natrium(methylprednisolon-21-succinat)
Reported
Reported 02.12.2025
Metypred 125mg GALEN
Natrium(methylprednisolon-21-succinat)
Supply-relevant
Reported 27.11.2025
Atorvastatin Aristo 80 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Reported 27.11.2025
Atorvastatin Aristo 80 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Reported 27.11.2025
Atorvastatin Aristo 80 mg Filmtabletten
Atorvastatin-Calcium-Trihydrat (Ph.Eur.)
Supply-relevant
Reported 26.11.2025
Gabapentin Holsten 800 mg Filmtabletten
Gabapentin
11 clinical trials →
Supply-relevant
Reported 26.11.2025
Gabapentin Holsten 800 mg Filmtabletten
Gabapentin
11 clinical trials →
Reported
Hospital-relevant Reported 18.11.2025
Javlor 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung - OP(1x2ml)
Vinfluninbis[(R,R)-tartrat]
Reported
Hospital-relevant Reported 18.11.2025
Javlor 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung - OP(1x2ml)
Vinfluninbis[(R,R)-tartrat]
Supply-relevant
Reported 04.11.2025
Gabapentin Holsten 300 mg Hartkapseln
Gabapentin
11 clinical trials →
Supply-relevant
Hospital-relevant Reported 23.10.2025
NeoRecormon 5000 IE Injektionslösung in Fertigspritze - OP6
Epoetin beta
Supply-relevant
Hospital-relevant Reported 23.10.2025
NeoRecormon 3000 IE Injektionslösung in Fertigspritze - OP6
Epoetin beta
Supply-relevant
Hospital-relevant Reported 23.10.2025
NeoRecormon 4000 IE Injektionslösung in Fertigspritze - OP6
Epoetin beta
Supply-relevant
Hospital-relevant Reported 23.10.2025
NeoRecormon 2000 IE Injektionslösung in Fertigspritze - OP6
Epoetin beta
Reported
Hospital-relevant Reported 09.09.2025
Visudyne 15 mg Pulver zur Herstellung einer Infusionslösung - OP1
Verteporfin
3 clinical trials →
Reported
Hospital-relevant Reported 09.09.2025
Procain 2 % JENAPHARM
Procainhydrochlorid
Reported
Hospital-relevant Reported 09.09.2025
Procain 2 % JENAPHARM
Procainhydrochlorid
Reported
Hospital-relevant Reported 09.09.2025
Procain 2 % JENAPHARM
Procainhydrochlorid
Reported
Hospital-relevant Reported 09.09.2025
Procain 1 % JENAPHARM
Procainhydrochlorid
Reported
Hospital-relevant Reported 09.09.2025
Procain 1 % JENAPHARM
Procainhydrochlorid
Reported
Hospital-relevant Reported 09.09.2025
Procain 1 % JENAPHARM
Procainhydrochlorid
Reported
Hospital-relevant Reported 09.09.2025
Procain 1 % JENAPHARM
Procainhydrochlorid
Reported
Reported 27.08.2025
Rosuvastatin Aristo 20 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 27.08.2025
Rosuvastatin Aristo 20 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 27.08.2025
Rosuvastatin Aristo 10 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 27.08.2025
Rosuvastatin Aristo 10 mg Filmtabletten
Rosuvastatin-Hemicalcium
Reported
Reported 27.08.2025
Melperon Aristo 50 mg Filmtabletten
Melperonhydrochlorid
Reported
Reported 27.08.2025
Melperon Aristo 50 mg Filmtabletten
Melperonhydrochlorid
Reported
Reported 27.08.2025
Melperon Aristo 100 mg Filmtabletten
Melperonhydrochlorid
Reported
Reported 27.08.2025
Melperon Aristo 100 mg Filmtabletten
Melperonhydrochlorid
Reported
Reported 27.08.2025
Melperon Aristo 100 mg Filmtabletten
Melperonhydrochlorid
Reported
Reported 27.08.2025
Azur compositum
Codeinphosphat-Hemihydrat; Coffein; Paracetamol
20 clinical trials →
Supply-critical
Reported 09.07.2025
Thevier 100
Levothyroxin-Natrium (Ph.Eur.)
Supply-critical
Reported 09.07.2025
Thevier 50
Levothyroxin-Natrium (Ph.Eur.)
Supply-critical
Reported 24.06.2025
Emselex 7,5 mg Retardtabletten - OP49
Darifenacinhydrobromid
Supply-critical
Reported 24.06.2025
Emselex 7,5 mg Retardtabletten - OP49
Darifenacinhydrobromid
Reported
Reported 11.06.2025
Spasmolyt 10mg
Trospiumchlorid
Reported
Reported 11.06.2025
Spasmolyt 10mg
Trospiumchlorid
Reported
Reported 11.06.2025
Spasmolyt 10mg
Trospiumchlorid
Reported
Reported 05.06.2025
Accusol 35 Hämodialyse-, Hämodiafiltrations-, Hämofiltrationslösung
Calciumchlorid-Dihydrat; Magnesiumchlorid-Hexahydrat; Natriumchlorid; Natriumhydrogencarbonat
Reported
Reported 15.01.2025
Novial
Desogestrel; Ethinylestradiol
Reported
Reported 15.01.2025
Novial
Desogestrel; Ethinylestradiol
Reported
Reported 15.01.2025
Novial
Desogestrel; Ethinylestradiol
Supply-critical
Hospital-relevant Reported 03.01.2025
Calciumfolinat Medipolis 10 mg/ml Injektionslösung
Calciumfolinat-Hydrat
Reported
Hospital-relevant Reported 29.11.2024
Thyrotardin-inject.
Liothyronin-Natrium
Reported
Reported 04.11.2024
Emselex 7,5 mg Retardtabletten - OP140(14x10)
Darifenacinhydrobromid
Supply-critical
Hospital-relevant Reported 18.09.2024
Calciumfolinat EVER Pharma 10 mg/ml Injektionslösung
Calciumfolinat
2 clinical trials →
Reported
Reported 01.10.2026
Quetiapin Accord 150mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 29.09.2026
Rosuvastatin/Ezetimib Denk 40 mg/10 mg Filmtabletten
Ezetimib; Rosuvastatin-Calcium (Ph.Eur.)
15 clinical trials →
Reported
Reported 29.09.2026
Rosuvastatin/Ezetimib Denk 20 mg/10 mg Filmtabletten
Ezetimib; Rosuvastatin-Calcium (Ph.Eur.)
15 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 35 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Supply-critical
Reported 04.08.2026
Buprenorphin-ratiopharm 35 Mikrogramm/h Transdermales Pflaster
Buprenorphin
6 clinical trials →
Reported
Reported 02.07.2026
Quetiapin Accord 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.07.2026
Quetiapin Accord 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Reported
Reported 02.07.2026
Quetiapin Accord 400 mg Retardtabletten
Quetiapinfumarat (Ph.Eur.)
Supply-critical
Hospital-relevant Reported 03.06.2026
IQYMUNE
Immunglobulin G vom Menschen
Supply-critical
Hospital-relevant Reported 03.06.2026
IQYMUNE
Immunglobulin G vom Menschen
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 100 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 100 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 80 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 80 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 80 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 40 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 40 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 40 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 40 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 25 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 25 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 25 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 25 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 18 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 18 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 18 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 10 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 10 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 10 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 60 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 60 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 27.01.2026
Atomoxetin-neuraxpharm 60 mg Hartkapseln
Atomoxetinhydrochlorid
3 clinical trials →
Reported
Reported 28.10.2025
Scintimun
Besilesomab
Reported
Reported 27.03.2023
Betoptima
Betaxololhydrochlorid
No shortages match your search.
Cite this page
Priya Life Science (2026). Germany Medicine Shortages Tracker. Available at: https://priyalifescience.com/germany-medicine-shortages (Accessed: 12 October 2026).
Data use permission: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) confirmed in writing on 18 September 2026 that data published on PharmNet.Bund may be used for this purpose ("The data published on website PharmNet.bund may be used for your purposes" - Jeanne Jansen-Weber, Unit 13.36, Supply and supply shortages).
Source: BfArM PharmNet.Bund Lieferengpassmeldungen - Germany's official medicine shortage notification register, refreshed twice daily. "Supply-critical" (versorgungskritisch) and "supply-relevant" (versorgungsrelevant) are BfArM's own severity classifications. This listing is informational and not medical advice; if a medicine you take is affected, speak to your pharmacist or doctor about alternatives. See also the EU Medicine Shortages Tracker, the US Drug Shortages Tracker, or browse every tracker in the Data Trackers hub.